Paper Details 
Original Abstract of the Article :
Benzimidazole anthelmintics have reported anti-neoplastic effects both in vitro and in vivo. The purpose of this study was to evaluate the in vitro chemosensitivity of three canine glioma cell lines to mebendazole and fenbendazole. The mean inhibitory concentration (IC<sub>50</sub> ) (&#177;SD) obta...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/vco.12288

データ提供:米国国立医学図書館(NLM)

Unveiling the Potential of Benzimidazole Anthelmintics in the Fight Against Canine Glioma: A Journey Through the Microtubule Desert

Imagine a desert of microtubules, the building blocks of cells, where cancerous cells are proliferating uncontrollably. This study explores the potential of benzimidazole anthelmintics, a type of drug typically used to combat parasitic worms, as a weapon against canine glioma, a type of brain tumor. Researchers are delving into the desert of cell biology to find new ways to target and destroy cancerous cells.

Targeting Microtubules: A Novel Approach to Treating Canine Glioma

The study found that mebendazole and fenbendazole, two benzimidazole anthelmintics, exhibited cytotoxic effects against canine glioma cells. These drugs are effective against parasitic worms by disrupting their microtubules, which are essential for cell division. This study suggests that a similar mechanism might be effective in inhibiting the growth of canine glioma cells, offering a new potential treatment approach. The researchers also observed that these drugs did not harm normal canine fibroblasts, suggesting a potential for selective targeting of cancer cells.

A New Frontier in Cancer Research: Exploring the Potential of Anthelmintics

This study opens a new frontier in cancer research, demonstrating the potential of repurposing existing drugs for new therapeutic applications. The findings highlight the importance of exploring the hidden potential of drug molecules beyond their traditional uses. Further in vivo studies are needed to confirm the efficacy and safety of these anthelmintics for treating canine gliomas, but the preliminary results are promising.

Dr. Camel's Conclusion

This study, like a caravan discovering a new oasis in a vast desert, reveals a potential new treatment for canine glioma. By repurposing benzimidazole anthelmintics, we may be able to find a new weapon in the fight against cancer, targeting the microtubules that are essential for the growth and survival of cancerous cells. Further research is needed to explore this promising avenue for therapeutic development.

Date :
  1. Date Completed 2018-07-23
  2. Date Revised 2018-07-23
Further Info :

Pubmed ID

28078780

DOI: Digital Object Identifier

10.1111/vco.12288

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.